• lawyer

    Posted on August 25th, 2011

    Written by mbersano

    Tags

    A judicial panel has decided that Darvon/Darvocet lawsuits will be consolidated for purposes of discovery.  The lawsuits will be part of multidistrict litigation, and will be centralized in federal court in Kentucky.

    At least 17 Darvon/Darvocet lawsuits will be transferred to the multidistrict litigation in the U.S. District Court for the Eastern District of Kentucky, and any new lawsuits filed will also be transferred there.  As part of discovery, Darvocet lawyers will research several issues – whether propoxyphene-containing medications like Darvon and Darvocet have defects that may be dangerous, and whether the defendants – Eli Lilly in the case of Darvon, and Xanodyne in the case of Darvocet – were aware of the dangerous side effects from the use of these medications.

    The defendants had argued against consolidation of all the lawsuits, saying that pretrial proceedings would likely focus on each individual plaintiff’s health.  However, the panel disagreed with the defendants, saying that the benefits of having multidistrict litigation outweigh the differences in individual cases.

    The move to centralize all Darvocet/Darvon lawsuits into single multidistrict litigation began in December 2010.  The petition was filed soon after a recall of all propoxyphene-containing painkillers.  The recall included both Darvocet and Darvocet as well as the generic versions.  The recall was announced in November 2010, when the Food and Drug Administration concluded that the use of propoxyphene-containing medications like Darvon and Darvocet increased the risk of cardiac disorders including cardiac arrhythmias or change in cardiac rhythm, tachycardia, ventricular fibrillation and myocardial infarction.

    The Food and Drug Administration panel that investigated the side effects of Darvon/Darvocet, also concluded that the side effects included suicidal fantasies, suicide risks, seizures and addiction.  Until the recall was announced, the FDA had received more than 3,000 reports of serious side effects resulting from Darvocet use.

    Share
    This entry was posted on Thursday, August 25th, 2011 at 8:12 pm and is filed under lawyer. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
  • 0 Comments

    Take a look at some of the responses we've had to this article.

  • Leave a Reply

    Let us know what you thought.

  • Name (required):

    Email (required):

    Website:

    Message: